Newsletter | April 29, 2024

04.29.24 -- A Promising Approach To Develop An Inhalable, Temperature-Stable COVID-19 Vaccine

FEATURED EDITORIAL

A Promising Approach To Develop An Inhalable, Temperature-Stable COVID-19 Vaccine

There are limitations to the currently available COVID-19 vaccines. An inhalable dry powder approach offers promising benefits, such as eliminating cold chain requirements, allowing for more widespread immunity.

INDUSTRY INSIGHTS

Nanoparticle Enabled Formulation And Drug Delivery Solutions

Review how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.

Gliding Towards De-Risked Combination Product Development

Learn about the critical role plunger stoppers play in determining a combination drug product's exposure to extractables and leachables.

Formulation Technologies For Developing Dry Powders For Inhalation

Examine challenges and key considerations for spray-dried formulations for inhalation, along with a review of current technologies and approved products utilizing particle engineering approaches.

Characterization And Delivery Of Ultra-Viscous And Non-Newtonian Formulations

Discover how to identify characteristics at the earliest stage, a vital step in autoinjector device platform development, with the use of the innovative injection characterization system (ICS).

Improving Cancer Medication Using Innovative ASD Technology

Review the case study and learn how a novel dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.

Delivering The Promise Of Gene Therapy

Gene therapies rely on efficient, precise methods of delivering genetic material. Examine how combining polymeric nanoparticles with CRISPR therapies is increasing the potential for improved treatment.

SOLUTIONS

Battelle uLAB

Get Your Biologic To Clinic And Market Faster

Taste Masking 101: Sensory And Performance Evaluation